18-54224280-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_003927.5(MBD2):c.280C>T(p.Arg94Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 929,224 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000051 ( 0 hom. )
Consequence
MBD2
NM_003927.5 missense
NM_003927.5 missense
Scores
4
5
10
Clinical Significance
Conservation
PhyloP100: -0.185
Genes affected
MBD2 (HGNC:6917): (methyl-CpG binding domain protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. The protein encoded by this gene may function as a mediator of the biological consequences of the methylation signal. It is also reported that the this protein functions as a demethylase to activate transcription, as DNA methylation causes gene silencing. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.2748693).
BS2
High AC in GnomAdExome4 at 40 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MBD2 | NM_003927.5 | c.280C>T | p.Arg94Cys | missense_variant | 1/7 | ENST00000256429.8 | NP_003918.1 | |
MBD2 | NM_015832.6 | c.280C>T | p.Arg94Cys | missense_variant | 1/3 | NP_056647.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MBD2 | ENST00000256429.8 | c.280C>T | p.Arg94Cys | missense_variant | 1/7 | 1 | NM_003927.5 | ENSP00000256429.3 | ||
MBD2 | ENST00000583046.1 | c.280C>T | p.Arg94Cys | missense_variant | 1/3 | 1 | ENSP00000464554.1 | |||
MBD2 | ENST00000398398.6 | c.280C>T | p.Arg94Cys | missense_variant | 1/3 | 2 | ENSP00000381435.2 |
Frequencies
GnomAD3 genomes AF: 0.0000140 AC: 2AN: 143294Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
2
AN:
143294
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000509 AC: 40AN: 785930Hom.: 0 Cov.: 14 AF XY: 0.0000357 AC XY: 13AN XY: 364342
GnomAD4 exome
AF:
AC:
40
AN:
785930
Hom.:
Cov.:
14
AF XY:
AC XY:
13
AN XY:
364342
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000140 AC: 2AN: 143294Hom.: 0 Cov.: 31 AF XY: 0.0000144 AC XY: 1AN XY: 69666
GnomAD4 genome
AF:
AC:
2
AN:
143294
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
69666
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.280C>T (p.R94C) alteration is located in exon 1 (coding exon 1) of the MBD2 gene. This alteration results from a C to T substitution at nucleotide position 280, causing the arginine (R) at amino acid position 94 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Benign
DEOGEN2
Benign
T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Pathogenic
D
MutationAssessor
Benign
N;.;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Uncertain
Sift
Pathogenic
D;D;.
Sift4G
Uncertain
T;T;T
Polyphen
D;.;D
Vest4
MutPred
Loss of methylation at R94 (P = 0.0012);Loss of methylation at R94 (P = 0.0012);Loss of methylation at R94 (P = 0.0012);
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at